Clinical Trials Browser

Not yet recruiting × Bile Duct Neoplasms × Gemcitabine × Clear all

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06274879 2025-01-09

Ablatio

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms